Showing results (271-280 of 307) with videos related to
Sort By:
Pageof 31
Journal of Medicinal Chemistry|April 14, 2006
Identification of ellagic acid as potent inhibitor of protein kinase CK2: a successful example of a virtual screening applicationGiorgio Cozza, Paolo Bonvini, Elisa Zorzi, et al.British Journal of Pharmacology|February 16, 2017
Phenolic 1,3-diketones attenuate lipopolysaccharide-induced inflammatory response by an alternative magnesium-mediated mechanismMorena Zusso, Giulia Mercanti, Federica Belluti, et al.Chembiochem : a European Journal of Chemical Biology|November 30, 2006
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitorsMario A Pagano, Giorgia Poletto, Giovanni Di Maira, et al.Journal of Medicinal Chemistry|March 24, 2009
Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studiesVittoria Colotta, Ombretta Lenzi, Daniela Catarzi, et al.Biochemistry|October 6, 2004
Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo studyFlavio Meggio, Mario A Pagano, Stefano Moro, et al.Journal of Medicinal Chemistry|January 11, 2011
Synthesis and biological evaluation of a new series of 1,2,4-triazolo[1,5-a]-1,3,5-triazines as human A(2A) adenosine receptor antagonists with improved water solubilityStephanie Federico, Silvia Paoletta, Siew Lee Cheong, et al.Bioorganic & Medicinal Chemistry|September 13, 2011
Does the combination of optimal substitutions at the C²-, N⁵- and N⁸-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A₃ adenosine receptors?Siew Lee Cheong, Anton V Dolzhenko, Silvia Paoletta, et al.Bioorganic Chemistry|September 15, 2020
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapyFernanda Rodríguez-Enríquez, María Carmen Costas-Lago, Pedro Besada, et al.Journal of Medicinal Chemistry|August 2, 2007
New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studiesVittoria Colotta, Daniela Catarzi, Flavia Varano, et al.Journal of Medicinal Chemistry|February 23, 2013
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluationLucia Squarcialupi, Vittoria Colotta, Daniela Catarzi, et al.Pageof 31